215 related articles for article (PubMed ID: 25647231)
1. Gender Differences in the Toxicokinetics of Triptolide after Single- and Multiple-dose Administration in Rats.
Liu L; Zhang J; Wang Z; Xu D; Jiang Z; Wang T; Ju W; Zhang L
Drug Res (Stuttg); 2015 Nov; 65(11):602-6. PubMed ID: 25647231
[TBL] [Abstract][Full Text] [Related]
2. Comparison of toxicokinetic and tissue distribution of triptolide-loaded solid lipid nanoparticles vs free triptolide in rats.
Xue M; Zhao Y; Li XJ; Jiang ZZ; Zhang L; Liu SH; Li XM; Zhang LY; Yang SY
Eur J Pharm Sci; 2012 Nov; 47(4):713-7. PubMed ID: 22677813
[TBL] [Abstract][Full Text] [Related]
3. Male reproductive toxicity and toxicokinetics of triptolide in rats.
Ni B; Jiang Z; Huang X; Xu F; Zhang R; Zhang Z; Tian Y; Wang T; Zhu T; Liu J; Zhang L
Arzneimittelforschung; 2008; 58(12):673-80. PubMed ID: 19202740
[TBL] [Abstract][Full Text] [Related]
4. Glycyrrhizin accelerates the metabolism of triptolide through induction of CYP3A in rats.
Tai T; Huang X; Su Y; Ji J; Su Y; Jiang Z; Zhang L
J Ethnopharmacol; 2014 Mar; 152(2):358-63. PubMed ID: 24486211
[TBL] [Abstract][Full Text] [Related]
5. Knockout of hepatic P450 reductase aggravates triptolide-induced toxicity.
Xue X; Gong L; Qi X; Wu Y; Xing G; Yao J; Luan Y; Xiao Y; Li Y; Wu X; Chen M; Gu J; Ren J
Toxicol Lett; 2011 Aug; 205(1):47-54. PubMed ID: 21596114
[TBL] [Abstract][Full Text] [Related]
6. Identification of in vivo and in vitro metabolites of triptolide by liquid chromatography-tandem mass spectrometry.
Peng ZH; Wang JJ; Du P; Chen Y
J Pharm Biomed Anal; 2012 Nov; 70():624-30. PubMed ID: 22824635
[TBL] [Abstract][Full Text] [Related]
7. [Pharmacokinetics of triptolide in Beagle dogs].
Shao F; Wang GJ; Sun JG; Xie HT; Zhang R; Zhu XY
Yao Xue Xue Bao; 2007 Jan; 42(1):61-5. PubMed ID: 17520809
[TBL] [Abstract][Full Text] [Related]
8. CYP3A4 inducer and inhibitor strongly affect the pharmacokinetics of triptolide and its derivative in rats.
Xu Y; Zhang YF; Chen XY; Zhong DF
Acta Pharmacol Sin; 2018 Aug; 39(8):1386-1392. PubMed ID: 29283173
[TBL] [Abstract][Full Text] [Related]
9. Compatibility with Panax notoginseng and Rehmannia glutinosa Alleviates the Hepatotoxicity and Nephrotoxicity of Tripterygium wilfordii via Modulating the Pharmacokinetics of Triptolide.
Zhang Q; Li Y; Liu M; Duan J; Zhou X; Zhu H
Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29351251
[No Abstract] [Full Text] [Related]
10. Pharmacokinetic study of triptolide, a constituent of immunosuppressive chinese herb medicine, in rats.
Shao F; Wang G; Xie H; Zhu X; Sun J; A J
Biol Pharm Bull; 2007 Apr; 30(4):702-7. PubMed ID: 17409506
[TBL] [Abstract][Full Text] [Related]
11. Kinetic release of triptolide after injection of renal-targeting 14-succinyl triptolide-lysozyme in a rat kidney study by liquid chromatography/mass spectrometry.
Zheng Q; Ye L; Gao R; Han J; Xiong M; Zhao D; Gong T; Zhang Z
Biomed Chromatogr; 2007 Jul; 21(7):724-9. PubMed ID: 17370252
[TBL] [Abstract][Full Text] [Related]
12. Sex differences in subacute toxicity and hepatic microsomal metabolism of triptolide in rats.
Liu L; Jiang Z; Liu J; Huang X; Wang T; Liu J; Zhang Y; Zhou Z; Guo J; Yang L; Chen Y; Zhang L
Toxicology; 2010 Apr; 271(1-2):57-63. PubMed ID: 20223271
[TBL] [Abstract][Full Text] [Related]
13. A sensitive LC-MS/MS method for the determination of triptolide and its application to pharmacokinetic research in rats.
Xu Y; Chen X; Zhong D
Biomed Chromatogr; 2019 Mar; 33(3):e4422. PubMed ID: 30374997
[TBL] [Abstract][Full Text] [Related]
14. Synchronous measuring of triptolide changes in rat brain and blood and its application to a comparative pharmacokinetic study in normal and Alzheimer's disease rats.
Zhu S; Wang X; Zheng Z; Zhao XE; Bai Y; Liu H
J Pharm Biomed Anal; 2020 Jun; 185():113263. PubMed ID: 32203895
[TBL] [Abstract][Full Text] [Related]
15. Nanostructured lipid carriers as a novel oral delivery system for triptolide: induced changes in pharmacokinetics profile associated with reduced toxicity in male rats.
Zhang C; Peng F; Liu W; Wan J; Wan C; Xu H; Lam CW; Yang X
Int J Nanomedicine; 2014; 9():1049-63. PubMed ID: 24591827
[TBL] [Abstract][Full Text] [Related]
16. Transdermal delivery of triptolide-phospholipid complex to treat rheumatoid arthritis.
Liu XY; Pei WJ; Wu YZ; Ren FL; Yang SY; Wang X
Drug Deliv; 2021 Dec; 28(1):2127-2136. PubMed ID: 34617835
[TBL] [Abstract][Full Text] [Related]
17. Integrated targeted sphingolipidomics and transcriptomics reveal abnormal sphingolipid metabolism as a novel mechanism of the hepatotoxicity and nephrotoxicity of triptolide.
Qu L; Qu F; Jia Z; Wang C; Wu C; Zhang J
J Ethnopharmacol; 2015 Jul; 170():28-38. PubMed ID: 25978956
[TBL] [Abstract][Full Text] [Related]
18. Development of triptolide-nanoemulsion gels for percutaneous administration: physicochemical, transport, pharmacokinetic and pharmacodynamic characteristics.
Yang M; Gu Y; Yang D; Tang X; Liu J
J Nanobiotechnology; 2017 Dec; 15(1):88. PubMed ID: 29202753
[TBL] [Abstract][Full Text] [Related]
19. Liquid chromatographic/mass spectrometry assay of triptolide in dog plasma and its application to pharmacokinetic study.
Shao F; Wang G; Sun J; Xie H; Li H; Liang Y; Zhang R; Zhu X
J Pharm Biomed Anal; 2006 May; 41(2):341-6. PubMed ID: 16413988
[TBL] [Abstract][Full Text] [Related]
20. [Pharmacokinetics of triptolide in Triptergium wilfordii microemulsion gel].
Guan Y; Yan Z; Chen L; Zhu W; Yang M
Zhongguo Zhong Yao Za Zhi; 2011 Jan; 36(2):216-9. PubMed ID: 21506426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]